These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25064471)

  • 1. Dosimetric predictors of esophageal toxicity after stereotactic body radiotherapy for central lung tumors.
    Wu AJ; Williams E; Modh A; Foster A; Yorke E; Rimner A; Jackson A
    Radiother Oncol; 2014 Aug; 112(2):267-71. PubMed ID: 25064471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local control and toxicity in a large cohort of central lung tumors treated with stereotactic body radiation therapy.
    Modh A; Rimner A; Williams E; Foster A; Shah M; Shi W; Zhang Z; Gelblum DY; Rosenzweig KE; Yorke ED; Jackson A; Wu AJ
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1168-76. PubMed ID: 25303891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting High-Grade Esophagus Toxicity After Treating Central Lung Tumors With Stereotactic Radiation Therapy Using a Normal Tissue Complication Probability Model.
    Duijm M; van der Voort van Zyp NC; van de Vaart P; Oomen-de Hoop E; Mast ME; Hoogeman MS; Nuyttens JJ
    Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):73-81. PubMed ID: 31499137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-Volume Predictors of Esophagitis After Thoracic Stereotactic Body Radiation Therapy.
    Harder EM; Chen ZJ; Park HS; Mancini BR; Decker RH
    Am J Clin Oncol; 2017 Oct; 40(5):477-482. PubMed ID: 26017483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esophageal dose tolerance to hypofractionated stereotactic body radiation therapy: risk factors for late toxicity.
    Stephans KL; Djemil T; Diaconu C; Reddy CA; Xia P; Woody NM; Greskovich J; Makkar V; Videtic GM
    Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):197-202. PubMed ID: 25015204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Esophagus toxicity after stereotactic and hypofractionated radiotherapy for central lung tumors: Normal tissue complication probability modeling.
    Duijm M; Tekatli H; Oomen-de Hoop E; Verbakel W; Schillemans W; Slotman BJ; Senan S; Nuyttens JJ
    Radiother Oncol; 2018 May; 127(2):233-238. PubMed ID: 29478763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for esophagitis after hypofractionated palliative (chemo) radiotherapy for non-small cell lung cancer.
    Nieder C; Imingen KS; Mannsåker B; Yobuta R; Haukland E
    Radiat Oncol; 2020 May; 15(1):91. PubMed ID: 32357936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic body radiotherapy for central lung tumors.
    Rowe BP; Boffa DJ; Wilson LD; Kim AW; Detterbeck FC; Decker RH
    J Thorac Oncol; 2012 Sep; 7(9):1394-9. PubMed ID: 22843088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Esophageal Dose Tolerance in Patients Treated With Stereotactic Body Radiation Therapy.
    Nuyttens JJ; Moiseenko V; McLaughlin M; Jain S; Herbert S; Grimm J
    Semin Radiat Oncol; 2016 Apr; 26(2):120-8. PubMed ID: 27000508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with three-dimensional conformal radiotherapy.
    Singh AK; Lockett MA; Bradley JD
    Int J Radiat Oncol Biol Phys; 2003 Feb; 55(2):337-41. PubMed ID: 12527046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low Incidence of Esophageal Toxicity After Lung Stereotactic Body Radiation Therapy: Are Current Esophageal Dose Constraints Too Conservative?
    Yau V; Lindsay P; Le L; Lau A; Wong O; Glick D; Bezjak A; Cho BCJ; Hope A; Sun A; Giuliani M
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):574-580. PubMed ID: 29680259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose coverage impacts local control in ultra-central lung oligometastases treated with stereotactic radiotherapy.
    Loi M; Franceschini D; Dominici L; Chiola I; Franzese C; D'Agostino GR; Navarria P; Marzo M; Paganini L; Comito T; Mancosu P; Tomatis S; Cozzi L; Alifano M; Scorsetti M
    Strahlenther Onkol; 2021 May; 197(5):396-404. PubMed ID: 32970163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and dosimetric predictors of radiation-induced esophageal toxicity.
    Maguire PD; Sibley GS; Zhou SM; Jamieson TA; Light KL; Antoine PA; Herndon JE; Anscher MS; Marks LB
    Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):97-103. PubMed ID: 10477012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment-related acute esophagitis for patients with locoregionally advanced non-small cell lung cancer treated with involved-field radiotherapy and concurrent chemotherapy.
    Bar-Ad V; Leiby B; Witek M; Xiao Y; Cui Y; Dai Y; Cao J; Axelrod R; Campling B; Both S; Werner-Wasik M
    Am J Clin Oncol; 2014 Oct; 37(5):433-7. PubMed ID: 23388558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Full Dose SBRT in Combination With Mediastinal Chemoradiation for Locally Advanced, Non-Small Cell Lung Cancer: A Practical Guide for Planning, Dosimetric Results From a Phase 2 Study, and a Treatment Planning Guide for the Phase 3 NRG Oncology LU-008 Trial.
    Heinzerling JH; Pen OV; Robinson M; Foster R; Kelly B; Mileham KF; Moeller B; Prabhu RS; Corso C; Ward MW; Sullivan CM; Burri S; Simone CB
    Pract Radiat Oncol; 2023; 13(6):531-539. PubMed ID: 37406774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of longitudinal and circumferential three-dimensional esophageal dose distribution predicts acute esophagitis in hypofractionated reirradiation of patients with non-small-cell lung cancer treated in stereotactic body frame.
    Poltinnikov IM; Fallon K; Xiao Y; Reiff JE; Curran WJ; Werner-Wasik M
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):652-8. PubMed ID: 15936541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetric correlations of acute esophagitis in lung cancer patients treated with radiotherapy.
    Takeda K; Nemoto K; Saito H; Ogawa Y; Takai Y; Yamada S
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):626-9. PubMed ID: 15936536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric correlates for acute esophagitis in patients treated with radiotherapy for lung carcinoma.
    Bradley J; Deasy JO; Bentzen S; El-Naqa I
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1106-13. PubMed ID: 15001251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric and clinical predictors of acute esophagitis in lung cancer patients in Turkey treated with radiotherapy.
    Etiz D; Bayman E; Akcay M; Sahin B; Bal C
    Asian Pac J Cancer Prev; 2013; 14(7):4223-8. PubMed ID: 23991980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of radiotherapy induced bone injury (RIBI) after stereotactic lung radiotherapy.
    Taremi M; Hope A; Lindsay P; Dahele M; Fung S; Purdie TG; Jaffray D; Dawson L; Bezjak A
    Radiat Oncol; 2012 Sep; 7():159. PubMed ID: 22985910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.